Deal Terms

Term Sheet Templates & Complete Guide for Founders

The definitive resource on venture capital term sheets — what every clause means, how to negotiate, NVCA templates, and real examples from seed through Series B.

What Is a Term Sheet?

A term sheet is a non-binding document that outlines the key financial and governance terms of a proposed investment. In venture capital, the term sheet is the critical inflection point in a fundraise — it signals that an investor is serious enough to put specific deal terms on paper, and it serves as the blueprint for the definitive legal agreements that follow. Think of a term sheet as a negotiation framework: it captures the essential deal points that both the investor and the founder must agree on before lawyers draft the stock purchase agreement, investor rights agreement, voting agreement, and other closing documents. Term sheets typically run 5 to 10 pages and cover economics (valuation, option pool, liquidation preference), control provisions (board composition, protective provisions, drag-along rights), and other terms (information rights, registration rights, no-shop clauses). While term sheets are generally non-binding, certain provisions — most commonly the no-shop/exclusivity clause and confidentiality — are explicitly binding. The no-shop clause prevents the company from soliciting other offers for a defined period (usually 30 to 60 days), giving the lead investor time to complete due diligence and close the deal. According to data from Carta and PitchBook, the median time from signed term sheet to close is approximately 45 to 60 days, though seed rounds may close in as few as two weeks if the investor uses standardized documents. Understanding every line of a term sheet is essential because these terms compound across rounds — a bad precedent set at seed or Series A will follow your cap table for the life of the company.

✓Non-binding document outlining key economic and governance terms of a proposed VC investment
✓Typically 5-10 pages covering valuation, liquidation preference, board seats, and protective provisions
✓Serves as the blueprint for definitive legal agreements: SPA, IRA, voting agreement, and ROFR/co-sale
✓No-shop clause (30-60 days) and confidentiality provisions are typically the only binding sections
✓Median time from signed term sheet to close: 45-60 days for priced rounds, as few as 2 weeks for seed
✓Terms set in early rounds create precedents that compound through Series A, B, and beyond

Term Sheet vs Contract vs LOI vs MOU

Founders often confuse term sheets with other pre-transaction documents, and the distinctions matter both legally and strategically. A term sheet is a non-binding summary of proposed deal terms used specifically in investment transactions — it outlines the economics and governance of a stock purchase but does not itself create a legal obligation to invest (except for binding provisions like no-shop and confidentiality). A letter of intent (LOI) is a similar pre-transaction document used primarily in M&A and commercial transactions. Like a term sheet, an LOI outlines proposed terms and is generally non-binding on the substantive deal points, but it may contain more extensive binding provisions around exclusivity, expense reimbursement, and break-up fees. In practice, 'term sheet' and 'LOI' are sometimes used interchangeably in venture capital, though purists reserve 'LOI' for acquisition contexts. A memorandum of understanding (MOU) is a broader document used in commercial partnerships, joint ventures, and international agreements. MOUs tend to be more formal than term sheets and may be partially or fully binding depending on the jurisdiction and the parties' intent. In some legal systems, a sufficiently detailed MOU can be interpreted as a binding contract. A contract (or definitive agreement) is a fully binding legal document that creates enforceable obligations. In the VC context, the definitive agreements — stock purchase agreement, investor rights agreement, voting agreement, right of first refusal and co-sale agreement, and the amended certificate of incorporation — are the binding contracts that supersede the term sheet. The term sheet's role is to align the parties on key terms before incurring the legal costs (typically $30K-$75K for the company) of drafting and negotiating these definitive documents. One important nuance: while term sheets are 'non-binding,' courts have occasionally found that parties acted in bad faith by walking away from a signed term sheet without legitimate cause, particularly when the company turned down other investors in reliance on the term sheet. This is why experienced founders always maintain backup options even after signing.

✓Term sheet: non-binding investment summary; only no-shop and confidentiality are binding
✓LOI (Letter of Intent): similar non-binding format used primarily in M&A and acquisitions
✓MOU (Memorandum of Understanding): more formal, may be partially binding depending on jurisdiction
✓Contract/definitive agreement: fully binding legal documents drafted from term sheet terms
✓Legal costs to draft definitive agreements from a term sheet typically run $30K-$75K for the company
✓Courts have found bad faith when parties abandon signed term sheets without legitimate cause

Anatomy of a VC Term Sheet: Every Key Clause

A standard venture capital term sheet is organized into several major sections, each containing clauses that have significant implications for founders. The preamble identifies the parties (investor and company), the type of security being issued (typically Series Seed Preferred or Series A Preferred Stock), and the total amount of the investment. The economic terms section covers the core financial deal: pre-money valuation, price per share, total investment amount, and the option pool. This section also includes the liquidation preference, participation rights, dividends, and anti-dilution protection — provisions that determine how money flows in an exit or liquidation event. The control terms section addresses governance: board composition (how many seats each party gets), protective provisions (investor veto rights over specific company actions), drag-along rights (forcing minority holders to approve a sale), and information rights (what financial and operational data the company must share). The additional terms section covers registration rights (the investor's ability to require the company to register shares for public sale), right of first refusal and co-sale (restrictions on founder stock transfers), founder vesting, and the no-shop clause. Finally, most term sheets include closing conditions — what must happen before the deal closes, such as satisfactory completion of due diligence, legal opinions, and board and stockholder approvals. Each of these clauses interacts with the others, which is why reviewing a term sheet in isolation clause-by-clause misses the full picture. For example, a 'fair' valuation can be undermined by an aggressive liquidation preference and a large option pool increase that comes out of the pre-money valuation. Experienced founders and their counsel evaluate term sheets holistically.

✓Preamble: identifies parties, security type (Series A Preferred), and total investment amount
✓Economic terms: valuation, price per share, option pool, liquidation preference, anti-dilution, dividends
✓Control terms: board composition, protective provisions, drag-along, information rights
✓Additional terms: registration rights, ROFR/co-sale, founder vesting, no-shop clause
✓Closing conditions: due diligence completion, legal opinions, board/stockholder approvals
✓Clauses interact — evaluate holistically rather than reviewing each term in isolation

Economic Terms: Valuation and Price Per Share

The valuation is the headline number that most founders fixate on, but it is only meaningful in context with all other economic terms. Venture capital term sheets express valuation as a pre-money valuation — the value assigned to the company before the new investment — and a post-money valuation, which equals the pre-money plus the investment amount. The price per share is calculated by dividing the pre-money valuation by the fully diluted share count (which includes a critical nuance discussed in the option pool section below). For example, if a company has a $20M pre-money valuation, raises $5M, and has 10M fully diluted shares, the price per share is $2.00 ($20M / 10M shares), and the investor receives 2.5M new shares ($5M / $2.00). The post-money valuation is $25M, and the investor owns 10% ($5M / $25M). However, the 'headline' valuation can be misleading. Two term sheets can offer the same $20M pre-money but result in dramatically different founder ownership depending on the option pool expansion, liquidation preference multiple, participation rights, and anti-dilution terms. According to Carta data for 2025, median pre-money valuations were approximately $10-12M for seed rounds, $35-45M for Series A, and $100-150M for Series B — but these figures vary widely by sector, geography, and market conditions. Founders should model the effective valuation by calculating their post-money ownership percentage after accounting for all economic terms, not just the headline number. This is sometimes called the 'effective price' or 'real economics' of the deal.

✓Pre-money valuation: company value before investment; post-money = pre-money + investment amount
✓Price per share = pre-money valuation divided by fully diluted share count (including expanded option pool)
✓Two identical headline valuations can yield different founder ownership based on other economic terms
✓2025 median pre-money: ~$10-12M seed, ~$35-45M Series A, ~$100-150M Series B (Carta data)
✓Model 'effective valuation' by calculating post-money ownership after all terms, not just headline price
✓Always confirm whether the option pool expansion is included in the pre-money or post-money calculation

Economic Terms: Option Pool and the Option Pool Shuffle

The option pool is one of the most commonly misunderstood — and most strategically important — elements of a venture capital term sheet. Most VC term sheets require the company to expand or create an employee stock option pool as a condition of closing, typically sized at 10-20% of the post-money fully diluted shares. The critical detail is where this pool comes from: in nearly all VC deals, the option pool expansion is carved out of the pre-money valuation, not the post-money. This is known as the 'option pool shuffle,' and it effectively reduces the true pre-money valuation from the founder's perspective. Here is how it works. Suppose you receive a term sheet with a $20M pre-money valuation and a $5M investment ($25M post-money), with a requirement to expand the option pool to 15% of post-money shares. That 15% pool equals $3.75M in value ($25M x 15%). Because this comes out of the pre-money, the 'effective' pre-money valuation for existing shareholders is only $16.25M ($20M - $3.75M). The investor still pays based on the $20M pre-money price per share, but founders and existing shareholders absorb the dilution of the new pool shares entirely. This means a $20M pre-money with a 15% pool expansion is economically equivalent to a $16.25M pre-money with no pool expansion — a significant difference. The NVCA model term sheet explicitly addresses this by specifying that the pre-money valuation includes the expanded option pool on a fully diluted basis. To negotiate effectively, founders should push for the smallest pool they can justify with a credible 18-24 month hiring plan, and they should always calculate the effective pre-money valuation to compare term sheets accurately. If one investor offers $18M pre-money with a 10% pool and another offers $20M with a 20% pool, the first deal may actually be better for founders. Building a detailed hiring budget with titles, salaries, and equity grant ranges is the most effective way to justify a smaller pool to investors.

✓Option pool typically sized at 10-20% of post-money fully diluted shares as a closing condition
✓The 'option pool shuffle': pool expansion comes from pre-money, reducing effective founder valuation
✓A $20M pre-money with 15% pool expansion = $16.25M effective pre-money for existing shareholders
✓Always calculate effective pre-money (headline pre-money minus pool expansion value) to compare offers
✓Justify a smaller pool with a detailed 18-24 month hiring plan including titles, roles, and grant sizes
✓NVCA model explicitly specifies that pre-money includes the expanded pool on a fully diluted basis

Economic Terms: Liquidation Preference

Liquidation preference determines who gets paid first — and how much — when a company is sold, merged, or wound down. It is arguably the most economically significant term in a VC term sheet after valuation. A standard liquidation preference is '1x non-participating preferred,' which means the investor receives whichever is greater: (a) 1x their original investment, or (b) their pro rata share of the proceeds as if they had converted to common stock. In a large exit, investors convert because their percentage ownership is worth more than 1x their money. In a small exit, the preference protects investors by guaranteeing they at least get their money back before common holders receive anything. Participating preferred — sometimes called 'double dip' — is significantly more aggressive. With participating preferred, the investor receives their 1x liquidation preference first AND then participates pro rata in the remaining proceeds alongside common holders. This means the investor gets paid twice: once from the preference stack and once from the participation. In a $50M exit where an investor put in $10M for 20%, non-participating preferred yields $10M (from the preference, since 20% of $50M = $10M, they are indifferent) while participating preferred yields $10M + 20% of the remaining $40M = $10M + $8M = $18M — a dramatic difference for founders. Participation is sometimes 'capped' at a specified multiple (e.g., 3x), meaning the investor stops participating once they have received 3x their investment in total. According to Fenwick & West data, approximately 70% of Series A deals in 2025 used 1x non-participating preferred, 20% used 1x participating with a cap, and 10% used 1x participating uncapped. Multiples above 1x (such as 2x or 3x liquidation preference) have become rare outside of distressed or late-stage deals. For a deeper analysis of liquidation preference mechanics, see our dedicated guide.

✓Standard: 1x non-participating preferred — investor gets back 1x investment OR converts to pro rata common (whichever is greater)
✓Participating preferred ('double dip'): investor gets 1x preference AND pro rata share of remaining proceeds
✓In a $50M exit with $10M invested at 20%, non-participating yields $10M vs participating yields $18M
✓Capped participation limits total payout to a specified multiple (e.g., 3x), then converts to common
✓~70% of 2025 Series A deals used 1x non-participating; multiples above 1x are increasingly rare
✓See /liquidation-preference-explained for a complete walkthrough with worked examples

Economic Terms: Anti-Dilution Protection

Anti-dilution provisions protect investors when a subsequent financing round occurs at a lower valuation than their original investment — a 'down round.' The mechanism works by adjusting the investor's conversion price downward, which grants them additional common shares upon conversion and offsets their loss in value. There are two primary types. Full ratchet anti-dilution resets the investor's conversion price all the way down to the new lower price, regardless of how small the down round is. A tiny bridge note at a reduced price can completely reprice an entire Series A investment, making full ratchet extremely punishing for founders. Broad-based weighted average anti-dilution, which is the industry standard used in approximately 95% of institutional deals, uses a formula that factors in both the magnitude of the price reduction and the relative size of the new issuance. The result is a proportional adjustment: small down rounds cause small repricing, and larger down rounds cause larger repricing. The 'broad-based' designation is critical because it means the formula denominator includes all shares on a fully diluted basis — common, preferred, options, warrants, and the option pool — producing a smaller, more founder-friendly adjustment. Narrow-based weighted average uses a smaller denominator (typically only preferred shares) and produces a larger adjustment. Founders should always insist on broad-based weighted average with carve-outs for employee option grants, advisor shares, and strategic equity issuances. Pay-to-play provisions, which require investors to participate in down rounds to retain their anti-dilution protection, provide an important counter-balance. For a comprehensive walkthrough of anti-dilution mechanics with worked examples and negotiation strategies, see our dedicated anti-dilution guide.

✓Protects investors in down rounds by adjusting conversion price downward, granting more shares upon conversion
✓Full ratchet: resets price to new lower round price regardless of round size — extremely founder-unfriendly
✓Broad-based weighted average: proportional adjustment based on round size — used in ~95% of deals
✓Always insist on broad-based (not narrow-based) with carve-outs for options, advisors, and strategic grants
✓Pay-to-play provisions require investor participation in down rounds to maintain anti-dilution rights
✓See /anti-dilution-explained for the full formula, worked examples, and negotiation playbook

Economic Terms: Dividends

Dividend provisions in venture capital term sheets specify whether preferred stockholders accrue dividends on their investment. The most common structure is 'non-cumulative dividends when, as, and if declared by the Board.' This means dividends are not guaranteed and only paid if the board explicitly declares them — which almost never happens at a venture-backed startup. The purpose of this clause is largely protective: it ensures that if the company ever does declare a dividend on common stock, preferred holders receive their share first (typically at 6-8% annually on the original investment amount). Non-cumulative means unpaid dividends do not accumulate over time, so they do not build up as a silent obligation. Cumulative dividends, by contrast, accrue whether or not the board declares them, typically at 6-8% per year. They compound annually and must be paid to preferred holders before any distribution to common stock, including at an exit. Over a 5-7 year holding period, cumulative 8% dividends can add 40-56% to the effective liquidation preference, dramatically shifting exit economics. For example, a $10M investment with 8% cumulative dividends held for 7 years would accrue $5.6M in dividends, making the effective preference $15.6M — meaning the company must generate $15.6M in exit proceeds before common holders receive anything. While cumulative dividends have become less common in standard venture deals, they appear in growth equity, late-stage rounds, and deals with strategic investors. Founders should push hard for non-cumulative dividends and understand the long-term compounding impact if cumulative terms are proposed. Some term sheets use a 'PIK' (payment in kind) structure where accrued dividends are paid in additional shares rather than cash, which creates additional dilution.

✓Standard: non-cumulative dividends 'when, as, and if declared' — board almost never declares them at startups
✓Protective provision ensuring preferred holders receive dividends before common if any are declared
✓Cumulative dividends accrue at 6-8% annually whether or not declared, adding to effective liquidation preference
✓Over 7 years, 8% cumulative dividends can add 56% to the effective preference ($10M becomes $15.6M)
✓PIK (payment in kind) dividends paid in additional shares create silent dilution over time
✓Push for non-cumulative; cumulative dividends are most common in growth equity and late-stage rounds

Control Terms: Board Composition

Board composition determines who controls the company's strategic direction and is often the most contentious governance provision in a term sheet. The board of directors approves major corporate actions including hiring and firing the CEO, approving budgets, authorizing new equity issuances, and deciding whether to accept acquisition offers. In early-stage deals (seed and Series A), the most common structure is a three-seat board: one seat for the lead investor, one for the CEO/founder, and one independent seat mutually agreed upon by both parties. This gives neither side unilateral control and creates a tie-breaking mechanism through the independent director. At Series A, some term sheets propose a five-seat board: two founder/common seats, two investor/preferred seats, and one independent. This structure maintains balance but gives the investor side more direct influence. By Series B and beyond, boards typically expand to five or seven seats, with additional investor seats often going to new lead investors. Founders should pay close attention to how the independent seat is selected — 'mutually agreed' is standard, but some term sheets give the preferred stockholders the right to designate the independent director, which effectively gives investors board control from day one. Board observer rights allow investors who do not have a formal seat to attend board meetings and receive all board materials. While observers cannot vote, their presence influences discussions and culture. Most term sheets also include provisions for board meetings (minimum quarterly), D&O insurance requirements, and expense reimbursement for investor directors. One critical negotiation point: founders should push for a provision that preserves their board representation even if new rounds add investor seats, and they should establish clear criteria for the independent director's qualifications and selection process.

✓Seed/Series A standard: 3-seat board — 1 investor, 1 founder/CEO, 1 mutually agreed independent
✓Series A alternative: 5-seat board — 2 common seats, 2 preferred seats, 1 independent
✓Independent director selection is critical — 'mutually agreed' is standard; avoid giving investors unilateral pick
✓Board observer rights allow non-seat investors to attend meetings and access materials without voting
✓Founders should negotiate provisions preserving their representation as new rounds add investor seats
✓Board approves CEO hiring/firing, budgets, equity issuances, and acquisition decisions — control matters

Control Terms: Protective Provisions (Investor Veto Rights)

Protective provisions are a set of specific corporate actions that require the approval of preferred stockholders (typically a majority or supermajority) in addition to the board and common stockholders. These provisions give investors veto power over decisions that could adversely affect their investment, even if the founders control the board. Standard protective provisions in the NVCA model term sheet include: issuing new equity senior to or on par with existing preferred stock, amending the certificate of incorporation in ways that adversely affect preferred stock rights, increasing or decreasing the authorized number of shares, declaring or paying dividends, redeeming or repurchasing shares (other than at cost from departing employees), changing the company's principal line of business, selling the company or substantially all of its assets, incurring debt above a specified threshold (e.g., $250K), and changing the size of the board. These provisions are designed to prevent founders from taking actions that would dilute or disadvantage existing investors without their consent. While protective provisions are standard and expected, founders should negotiate to ensure they are reasonable in scope. Watch for overly broad provisions that require investor consent for routine business operations — for example, a provision requiring consent for any contract above $50K could make it nearly impossible to sign a major customer or vendor agreement without investor approval. Also watch for provisions that aggregate voting across all preferred series ('voting as a single class') versus allowing each series to vote separately — the former gives a single large investor less blocking power, while the latter can give any series holder a unilateral veto. The goal is to give investors legitimate protections against fundamental changes while preserving the company's ability to operate nimbly in day-to-day business.

✓Investor veto rights over specific corporate actions — issuing senior equity, amending charter, selling the company
✓Standard provisions: new share issuances, dividends, debt above a threshold, board size changes, asset sales
✓Watch for overly broad provisions requiring consent for routine contracts, hires, or operational decisions
✓Voting 'as a single class' (all preferred together) vs series-by-series voting affects blocking power dynamics
✓NVCA model includes approximately 10-12 standard protective provisions — review each carefully
✓Goal: legitimate investor protection against fundamental changes without impeding daily operations

Control Terms: Drag-Along Rights and Information Rights

Drag-along rights allow a specified majority of shareholders (typically the board plus holders of a majority of common and preferred stock, voting together) to force all shareholders to approve a sale of the company. Without drag-along provisions, a minority shareholder could block an acquisition that the majority supports, creating a hold-up problem. Drag-along rights solve this by ensuring that once the specified threshold approves a sale, all shareholders must tender their shares on the same terms. The key negotiation points around drag-along are the approval threshold (what percentage must approve) and whether preferred holders voting as a class can trigger the drag-along without common holder consent. Founders should push for a structure that requires both a majority of common and a majority of preferred, rather than allowing either group to drag the other unilaterally. Some term sheets include a minimum price threshold — the drag-along only activates if the acquisition price exceeds a specified amount (e.g., 3x the total invested capital), preventing investors from dragging founders into a fire-sale acquisition that benefits the preference stack but leaves common holders with nothing. Information rights require the company to provide investors with regular financial and operational reporting. Standard information rights include: annual audited financial statements, quarterly unaudited statements, monthly management reports, and an annual operating budget. These are reasonable and expected — investors have a fiduciary duty to their LPs and need visibility into their portfolio companies. The negotiation points are the timing of delivery (e.g., quarterly statements within 45 days of quarter-end), the level of detail required, and whether information rights extend to all investors or only those holding a minimum threshold of shares (e.g., 'major investors' holding at least $1M in preferred stock). Some term sheets also include inspection rights, allowing investors to examine the company's books and records, and management rights letters that institutional VCs need for regulatory compliance.

✓Drag-along: allows a specified shareholder majority to force all holders to approve a company sale
✓Negotiate to require both common and preferred majority approval, not either group acting unilaterally
✓Consider a minimum price threshold (e.g., 3x invested capital) to prevent fire-sale drag-alongs
✓Information rights: annual audited financials, quarterly statements, monthly reports, annual budget
✓Rights typically limited to 'major investors' holding a minimum threshold (e.g., $1M+ in preferred)
✓Management rights letters needed by institutional VCs for regulatory compliance with their LPs

NVCA Model Term Sheet Walkthrough

The National Venture Capital Association (NVCA) publishes a set of model legal documents that serve as the industry standard for venture capital transactions. The NVCA model term sheet is the most widely referenced template in U.S. venture capital, and virtually all major law firms use it as a starting point for drafting. The model documents are freely available at nvca.org and are updated periodically to reflect evolving market practices. The NVCA model term sheet is organized into several sections. The 'Offering Terms' section covers the security type, closing date, and aggregate investment amount. The 'Charter' section covers dividends, liquidation preference, conversion mechanics, anti-dilution, pay-to-play, and redemption rights. The 'Stock Purchase Agreement' section addresses representations and warranties, conditions to closing, and expense reimbursement. The 'Investor Rights Agreement' section covers registration rights, information rights, and ROFR on new issuances. The 'Right of First Refusal and Co-Sale Agreement' section addresses restrictions on founder stock transfers. The 'Voting Agreement' section covers board composition, drag-along, and other voting arrangements. One of the most valuable features of the NVCA model is its use of bracketed alternatives that show different options for each provision — for example, [broad-based/narrow-based] for anti-dilution and [non-participating/participating/participating with cap] for liquidation preference. These brackets make explicit the negotiation points in every clause. The model also includes extensive footnotes explaining the purpose and market context for each provision, making it an excellent educational tool for first-time founders. Founders should download the NVCA model documents before entering any term sheet negotiation. By understanding the standard framework, you can quickly identify when an investor's term sheet deviates from market norms and focus your negotiation energy on the provisions that actually matter for your specific situation. Working with experienced counsel who is familiar with the NVCA models is essential — they can flag non-standard terms and benchmark your deal against current market data from surveys by Fenwick & West, Cooley, and Wilson Sonsini.

✓NVCA model term sheet is the industry standard template used by virtually all major VC law firms
✓Freely available at nvca.org — includes term sheet, SPA, IRA, voting agreement, ROFR/co-sale, and charter
✓Uses bracketed alternatives (e.g., [broad-based/narrow-based]) to show negotiation options for each clause
✓Includes extensive footnotes explaining purpose and market context for every provision
✓Covers all key sections: offering terms, charter, SPA, investor rights, ROFR/co-sale, and voting agreement
✓Download and study before any negotiation — knowing the standard framework is your best preparation

Term Sheet Red Flags Every Founder Should Know

While every term sheet requires negotiation, certain provisions are serious red flags that signal an adversarial investor relationship or economically punitive terms. Full ratchet anti-dilution is the most commonly cited red flag — as discussed above, it allows a tiny down round to completely reprice a large prior investment. Participating preferred with no cap (sometimes called 'double dip') dramatically reduces founder economics at exit by allowing investors to receive both their liquidation preference and their pro rata share of remaining proceeds. Cumulative dividends at high rates (8%+) silently erode founder economics over time, adding substantially to the effective liquidation preference. A liquidation preference multiple above 1x (e.g., 2x or 3x) means the investor gets 2-3 times their money back before any distribution to common holders, which can make moderate exits worthless for founders. Founder vesting resets — requiring founders to re-vest their shares from scratch — can leave you with nothing if you are terminated early. Overly broad protective provisions that require investor consent for routine business decisions can effectively give the investor operational control. Redemption rights allowing investors to force the company to buy back their shares at a specified date (typically 5-7 years) create a ticking debt obligation that can force a fire sale. Watch for unusually long no-shop periods (beyond 60 days) that prevent you from entertaining other offers while the investor completes slow-moving diligence. Also be wary of 'ratchet' provisions tied to milestones — these give the investor additional shares if the company fails to meet specific revenue or product targets, creating misaligned incentives. Finally, pay attention to who pays legal fees: the company paying the investor's legal costs is standard (typically capped at $25-50K), but uncapped fee provisions can be costly. Any red flag should prompt a conversation with your counsel about whether this investor is likely to be a constructive board member and partner.

✓Full ratchet anti-dilution: disproportionately punishes founders in any down round regardless of size
✓Participating preferred (uncapped): investors get preference AND pro rata share — 'double dip'
✓Cumulative dividends at 8%+: silently adds 40-56% to effective liquidation preference over 5-7 years
✓Liquidation preference above 1x (2x, 3x): makes moderate exits worthless for common holders
✓Founder vesting resets: re-vesting from scratch can leave you with nothing if terminated
✓Milestone ratchets, redemption rights, and overly broad protective provisions signal adversarial terms

How to Negotiate a Term Sheet

Negotiating a term sheet effectively requires preparation, leverage awareness, and strategic prioritization. The most important preparation step is understanding your BATNA (Best Alternative to a Negotiated Agreement) — do you have other term sheets, strong investor interest from other funds, or enough runway to walk away? Your leverage directly determines how hard you can push. If you have multiple term sheets, you have significant leverage; if you have six months of runway and one interested investor, your leverage is limited. Start by identifying the 3-5 provisions that matter most for your specific situation. For most founders, these are: valuation (including effective valuation after option pool), liquidation preference (1x non-participating vs. participating), board composition, and anti-dilution type. Focus your negotiation energy here and be willing to concede on less impactful terms. Use the NVCA model as your benchmark — if the investor's term sheet deviates from the NVCA standard on a given provision, ask why. Investors who propose non-standard terms should have a clear rationale. Engage experienced startup counsel early. Firms like Cooley, Gunderson, Wilson Sonsini, Fenwick & West, and Goodwin negotiate these deals daily and can tell you what is 'market' versus what is a reach. Good counsel pays for itself many times over by identifying issues you would miss. Negotiate in person or by phone, not over email — tone and relationship matter enormously. Always remain professional and solution-oriented. Frame pushbacks as 'alignment' rather than adversarial: instead of 'we won't accept participating preferred,' try 'we think 1x non-participating aligns us both toward a strong exit outcome.' Time your counter-proposals strategically — respond within 48-72 hours with a clear, organized markup or response memo rather than negotiating provision-by-provision over weeks. Be transparent about what matters most to you and ask the investor what matters most to them. Often, term sheet negotiations are not zero-sum: founders care most about valuation and option pool, while investors care most about governance and downside protection. Finding these complementary priorities creates space for mutual wins.

✓Know your BATNA: multiple term sheets give leverage; limited options require more flexibility
✓Prioritize 3-5 key provisions: valuation, liquidation preference, board composition, anti-dilution
✓Use the NVCA model as your benchmark — ask investors to justify any deviations from market standard
✓Engage experienced startup counsel (Cooley, Gunderson, WSGR, Fenwick) who benchmark against market data
✓Negotiate by phone or in person, not email — frame pushbacks as alignment, not adversarial demands
✓Respond within 48-72 hours with an organized markup; find complementary priorities for mutual wins

Term Sheets for Seed Rounds

Seed-stage term sheets have evolved significantly over the past decade. While SAFEs and convertible notes dominate the very earliest fundraising (pre-seed and small seed rounds under $2M), priced seed rounds using preferred stock have become increasingly common for larger seeds ($2-5M+), particularly when institutional seed funds are leading. A priced seed round uses a simplified version of the standard Series A term sheet, often based on the NVCA model or the Series Seed documents (a set of open-source, simplified venture financing documents maintained by Fenwick & West). Seed term sheets are typically shorter and simpler than Series A documents. Common features include: 1x non-participating liquidation preference (virtually universal at seed), broad-based weighted average anti-dilution, no board seat for the investor (or a single board observer seat), minimal protective provisions (often just 3-5 standard items rather than the full NVCA list), and no registration rights. Valuation caps for seed preferred typically range from $8-15M pre-money depending on the market, sector, and team. The option pool at seed is usually set at 10-15% of post-money shares, smaller than the 15-20% typical at Series A. One key difference in seed term sheets is founder vesting. While Series A investors usually inherit existing vesting schedules, seed investors sometimes negotiate for founders to restart or extend their vesting. The standard founder vesting schedule is 4 years with a 1-year cliff, and founders who have been working on the company pre-funding should receive credit for time served. Seed term sheets may also include pro rata rights (the right for the seed investor to participate in future rounds to maintain their percentage ownership), which are standard and reasonable at any stage. For rounds under $2M, a SAFE or convertible note is often more appropriate than a priced round — the legal costs are significantly lower ($5-10K vs. $25-50K) and the process is faster. However, a priced seed round gives both founders and investors a clear cap table from day one, which can simplify future fundraising.

✓Priced seed rounds increasingly common for $2-5M+ institutional seeds using Series Seed or simplified NVCA docs
✓Standard seed terms: 1x non-participating, broad-based weighted average, no board seat or observer only
✓Fewer protective provisions (3-5 standard items) and no registration rights compared to Series A
✓Seed pre-money valuations typically $8-15M; option pool 10-15% of post-money (smaller than Series A)
✓Founder vesting: 4 years with 1-year cliff; negotiate credit for pre-funding time served
✓For rounds under $2M, SAFEs or convertible notes are often more appropriate — lower cost, faster close

Term Sheets for Series A Rounds

Series A is where term sheet complexity increases substantially. The lead Series A investor is typically an institutional venture capital fund investing $5-15M, and they will negotiate a full set of economic, governance, and protective terms using the NVCA model as a baseline. The Series A term sheet establishes the precedent for all future rounds, making it the most consequential term sheet a founder will negotiate. Economic terms at Series A include: a pre-money valuation typically in the $25-50M range (2025 market data), 1x non-participating liquidation preference (standard), broad-based weighted average anti-dilution, an option pool expansion to 15-20% of post-money shares, and non-cumulative dividends. Participation rights are uncommon but not unheard of at Series A — approximately 20% of deals include some form of participation, usually capped at 2-3x. Governance terms are where Series A gets interesting. The lead investor will take a board seat, typically resulting in a 3 or 5 person board with an independent director. They will negotiate a full set of protective provisions covering equity issuances, charter amendments, debt, dividends, and asset sales. They will also establish information rights requiring monthly and quarterly financial reporting. The investor rights agreement negotiated at Series A creates the framework for all future investors. Founders should pay particular attention to the voting agreement, which determines how board seats are allocated and may include provisions for future rounds to add seats. The right of first refusal and co-sale agreement restricts founder stock transfers — founders cannot sell secondary shares without offering them first to the company (ROFR) and then to the investors (co-sale right). This prevents founders from cashing out before investors. Expense reimbursement provisions typically require the company to pay the lead investor's legal fees up to a cap ($25-50K is standard). Founders should also negotiate for a reasonable no-shop period (30-45 days) and ensure the closing conditions are achievable within the specified timeline.

✓Series A sets precedent for all future rounds — the most consequential term sheet a founder negotiates
✓Typical economics: $25-50M pre-money, 1x non-participating, broad-based weighted average, 15-20% option pool
✓Lead investor takes a board seat; 3 or 5 person board with an independent director is standard
✓Full protective provisions, information rights, ROFR/co-sale, and registration rights negotiated at Series A
✓Investor legal fee reimbursement: $25-50K cap is standard; push back on uncapped provisions
✓No-shop period: 30-45 days is standard; push back on periods longer than 60 days

Term Sheets for Series B and Later Rounds

Series B and later-stage term sheets build on the framework established at Series A but introduce additional complexity from multiple investor classes, higher stakes, and more sophisticated financial structures. At Series B ($15-50M+ rounds at $100-300M+ pre-money valuations in 2025), the new lead investor joins existing Series A investors, and the term sheet must address how the new preferred series interacts with existing preferred stock. Key considerations at Series B and beyond include stacking liquidation preferences: each series of preferred stock has its own liquidation preference, and in an exit, they are typically paid in reverse chronological order (last money in, first money out). If a company has raised $5M Series A and $20M Series B, both with 1x preference, the first $25M of exit proceeds goes to preferred holders before common holders receive anything. This stacking effect can make moderate exits ($30-50M) nearly worthless for founders even though the headline exit sounds impressive. Board composition becomes more complex as new investors want representation. A common Series B structure is a 7-seat board: 2 common seats, 3 investor seats (1 each for Series A lead, Series B lead, and possibly a third investor or observer converted to a seat), and 2 independent directors. Founders must negotiate carefully to maintain meaningful board influence. Information rights may be expanded to include more detailed reporting, KPI dashboards, and advance notice of material events. Pro rata rights (the right for existing investors to maintain their ownership percentage in new rounds) become particularly important — oversubscribed later rounds may need to cut allocations, and pro rata rights determine the pecking order. Some Series B term sheets introduce structural terms like milestone-based tranches (where the investment is released in stages as the company hits agreed-upon targets), which give investors additional control. Later rounds may also include redemption rights (allowing investors to force the company to repurchase their shares after a specified period, usually 5-7 years) and IPO ratchets (guaranteeing investors a minimum return in an IPO). These later-stage provisions reflect the increased capital at risk and the investors' need to generate returns for their LPs within a fund's lifecycle.

✓Stacking liquidation preferences: multiple rounds create a preference stack that must be satisfied before common holders receive proceeds
✓Series B typical: $15-50M+ invested at $100-300M+ pre-money, 1x non-participating standard
✓Board expansion: 7 seats common at Series B — 2 common, 3 investor, 2 independent
✓Pro rata rights determine allocation priority when later rounds are oversubscribed
✓Milestone-based tranches release capital in stages as the company hits agreed targets
✓Later-stage terms may include redemption rights (5-7 year buyback) and IPO ratchets (minimum return guarantees)

Timeline from Term Sheet to Close

Understanding the timeline from signed term sheet to closing is essential for cash flow planning and managing the fundraising process. The overall timeline varies by round type and complexity, but founders should plan for 4-8 weeks for a standard Series A. The first phase is due diligence (1-3 weeks), during which the investor's team and counsel review the company's financials, contracts, IP ownership, employment agreements, cap table, corporate records, and any litigation or regulatory issues. Smart founders prepare a data room before the term sheet is signed to accelerate this phase — a well-organized data room can cut diligence time by 50%. Common diligence issues that cause delays include unclear IP assignment (did all founders and contractors sign invention assignment agreements?), cap table discrepancies (do SAFE conversion calculations match?), and employment law compliance (are contractors properly classified?). The second phase is legal document drafting and negotiation (2-4 weeks). The investor's counsel (typically paid for by the company) drafts the definitive agreements based on the term sheet: stock purchase agreement, investor rights agreement, voting agreement, ROFR/co-sale agreement, and the amended and restated certificate of incorporation. The company's counsel reviews and redlines these documents, and the parties negotiate the details. Even when the term sheet was clear, legal drafting surfaces issues that require additional negotiation — this is normal and expected. The third phase is signing and closing (1-2 weeks). All parties execute the definitive agreements, the company files the amended certificate of incorporation with the Secretary of State (typically Delaware), the investor wires the funds, and the company issues the shares. Some deals close in a single day; others have a split signing and closing with the wire arriving a few days after signing. For seed rounds using SAFEs, the entire process can take as little as 1-2 weeks since no definitive agreements need to be drafted. For Series B and later, expect 6-10 weeks due to the additional complexity of multi-party negotiations and larger due diligence scope.

✓Standard Series A: 4-8 weeks from signed term sheet to funds in the bank
✓Phase 1 — due diligence (1-3 weeks): financials, IP, contracts, employment, cap table review
✓Phase 2 — legal drafting and negotiation (2-4 weeks): SPA, IRA, voting agreement, charter amendment
✓Phase 3 — signing and closing (1-2 weeks): execution, filing, wire transfer, share issuance
✓SAFE/convertible note rounds: as fast as 1-2 weeks with minimal documentation
✓Prepare a data room before term sheet signing to accelerate diligence and reduce delays by up to 50%

Sample Term Sheet Structure: What to Expect

A well-organized venture capital term sheet follows a standard structure that experienced investors and founders recognize immediately. Below is the typical outline you will encounter, based on the NVCA model and common market practice. Section 1 — Offering Terms: company name, investor names, security type (Series A Preferred Stock), aggregate investment amount, price per share, pre-money valuation, and closing date. Section 2 — Charter Terms (Economic Rights of Preferred Stock): dividends (non-cumulative, 6-8%), liquidation preference (1x non-participating), conversion rights (voluntary and automatic upon IPO at a threshold), anti-dilution (broad-based weighted average), and redemption (if any). Section 3 — Stock Purchase Agreement: representations and warranties (standard reps about corporate status, IP, contracts, litigation), closing conditions (satisfactory diligence, legal opinions), and counsel/expenses. Section 4 — Investor Rights Agreement: registration rights (S-1 demand and piggyback), information rights (annual, quarterly, monthly financials), pro rata rights (right to participate in future rounds), and board observer rights. Section 5 — Voting Agreement: board composition (seats, independent directors), drag-along rights, and protective provisions (investor veto rights). Section 6 — ROFR and Co-Sale: right of first refusal on founder stock transfers, co-sale right allowing investors to sell alongside founders, and exceptions (estate planning, family transfers). Section 7 — Other Terms: founder vesting and activity, no-shop clause (typically 45-60 days), confidentiality, governing law (typically Delaware or California), and expiration date for the term sheet itself. This structure ensures that all critical terms are addressed and provides a clear framework for both parties to negotiate. Founders receiving their first term sheet should map each section to the explanations in this guide and discuss any unfamiliar terms with their counsel before responding.

✓Section 1 — Offering Terms: parties, security type, amount, price per share, valuation, closing date
✓Section 2 — Charter Terms: dividends, liquidation preference, conversion, anti-dilution, redemption
✓Section 3 — SPA Terms: representations, warranties, closing conditions, expenses
✓Section 4 — Investor Rights: registration, information, pro rata rights, board observer
✓Section 5 — Voting Agreement: board composition, drag-along, protective provisions
✓Section 6 — ROFR/Co-Sale: transfer restrictions, co-sale, exceptions for estate/family transfers

Term Sheet Mistakes Founders Make

Even experienced founders make costly mistakes when evaluating and negotiating term sheets. The most common mistake is fixating on valuation while ignoring economic terms that dramatically affect real outcomes. A $30M pre-money with 2x participating preferred and a 20% option pool expansion is worse for founders than a $22M pre-money with 1x non-participating and a 10% pool in virtually every exit scenario below $200M. Run the math on multiple exit scenarios before celebrating a high headline valuation. The second most common mistake is failing to engage experienced counsel early enough. First-time founders sometimes use a general business attorney or try to review term sheets themselves to save on legal fees. Startup-experienced counsel costs $500-700/hour but will save you multiples of that in better terms and avoided pitfalls. Third, founders often underestimate the importance of relationship dynamics with their lead investor. The partner who sits on your board will be involved in every major company decision for 7-10 years. Before signing a term sheet, talk to founders of their other portfolio companies about their experience — an investor who is difficult during term sheet negotiation is signaling how they will behave as a board member. Fourth, founders accept terms because 'we can fix it in the next round.' This rarely happens. Terms established in prior rounds create a floor — future investors will want at least the same protections, and existing investors will resist giving up rights they already hold. Fifth, founders fail to negotiate as a team. If you have a co-founder, align on priorities and red lines before entering negotiations. Conflicting signals from co-founders weaken your position. Finally, many founders sign the no-shop clause without understanding its implications — during the exclusivity period, you cannot solicit or accept competing offers, so if the deal falls through, you have lost weeks of fundraising momentum.

✓Do not fixate on valuation — model real outcomes across multiple exit scenarios with all economic terms
✓Engage startup-experienced counsel early ($500-700/hr pays for itself many times over in better terms)
✓Reference-check your lead investor with 3-5 existing portfolio company founders before signing
✓Terms compound across rounds — do not assume you can 'fix it later' because you almost never can
✓Align with co-founders on priorities and red lines before negotiations begin to present a unified front
✓Understand the no-shop clause: you lose 30-60 days of fundraising momentum if the deal falls through

Frequently Asked Questions

Is a term sheet legally binding?

A term sheet is generally non-binding on the substantive deal terms (valuation, liquidation preference, board composition, etc.). However, certain provisions are explicitly binding: the no-shop/exclusivity clause (preventing the company from soliciting competing offers for 30-60 days), confidentiality provisions, and sometimes expense reimbursement obligations. The non-binding nature means either party can walk away from the deal before definitive agreements are signed, though doing so without legitimate cause after the other party has incurred significant reliance costs can, in rare cases, give rise to claims of bad faith. In practice, once a reputable investor signs a term sheet, they close the deal more than 95% of the time — walking away is extremely damaging to an investor's reputation.

How long does it take to close after signing a term sheet?

The timeline from signed term sheet to closing (funds in the bank) depends on the round type. SAFE rounds can close in as little as 1-2 weeks since minimal documentation is needed. Priced seed rounds typically take 2-4 weeks. Series A rounds take 4-8 weeks, covering due diligence (1-3 weeks), legal document drafting and negotiation (2-4 weeks), and signing/closing (1-2 weeks). Series B and later rounds may take 6-10 weeks due to multi-party negotiations and broader diligence scope. The single biggest factor in timeline is diligence preparation — having an organized data room ready before the term sheet is signed can cut 1-2 weeks off the overall timeline.

Can you negotiate a term sheet?

Absolutely — term sheets are designed to be negotiated. The term sheet is the appropriate stage to negotiate because legal costs have not yet been incurred on definitive documents. Most VCs expect founders to push back on 3-5 provisions and present a counter-proposal within 48-72 hours. Key negotiation areas include valuation, option pool size, liquidation preference type, board composition, and protective provision scope. Your leverage depends on your alternatives (other term sheets, strong investor interest, sufficient runway) and the competitive dynamics of your fundraise. Even with limited leverage, you should push for market-standard terms on the NVCA baseline provisions — most investors will concede on terms they know are non-standard.

What happens if a term sheet falls through?

If a term sheet falls through before definitive agreements are signed, the non-binding provisions lapse and neither party has further obligations (except that confidentiality obligations typically survive). However, the practical consequences can be significant: you have lost 4-8 weeks of fundraising momentum during the no-shop period, other investors may have moved on, and the market may perceive the failed deal negatively. To mitigate these risks, maintain warm relationships with backup investors throughout the term sheet period, keep your fundraising pipeline active (within the bounds of the no-shop clause), and ensure you have enough runway to restart the process if needed. If the deal falls through due to a diligence finding, address the issue before approaching other investors.

Should I use a lawyer for a term sheet?

Yes — engaging experienced startup counsel is one of the highest-ROI decisions a founder can make. A lawyer who regularly handles venture capital transactions can review a term sheet in 2-3 hours and identify non-standard terms, potential traps, and negotiation opportunities that first-time founders would miss. The cost ($1,000-2,000 for a term sheet review) is trivial compared to the economic impact of terms that will govern your company for years. Choose a firm with a dedicated startup/venture practice — Cooley, Gunderson Dettmer, Wilson Sonsini, Fenwick & West, and Goodwin are among the most active. Many of these firms offer deferred-fee arrangements for early-stage startups, charging reduced or no fees until the round closes.

What is the difference between a term sheet and a SAFE?

A term sheet outlines terms for a priced equity round (issuing preferred stock at a specific price per share), while a SAFE (Simple Agreement for Future Equity) is itself a simple investment instrument that converts into preferred stock at a future priced round. A SAFE is a binding legal agreement — when an investor signs a SAFE and sends the wire, the investment is complete. A term sheet is non-binding and merely sets the framework for definitive documents that take weeks to draft. SAFEs are standard for pre-seed and small seed rounds (under $2M) due to their simplicity and low legal costs ($5-10K vs. $25-75K for a priced round). For larger rounds where investors want specific governance rights, board seats, and detailed economic terms, a priced round with a formal term sheet is more appropriate.

How many term sheets should I try to get?

The ideal scenario is to have 2-3 term sheets from credible investors. Multiple term sheets give you negotiating leverage on valuation and terms, validation that your company is fundable, and optionality if one deal falls through. However, the goal is not to maximize the number of term sheets — it is to run an efficient process that generates competition among your top-choice investors. To achieve this, run a tight fundraising process: meet with 20-30 target investors over 2-3 weeks, create artificial urgency through a structured timeline, and guide your top prospects toward simultaneous decisions. Be transparent with investors about your timeline and process. Attempting to pit investors against each other dishonestly will backfire — the VC community is small and reputation travels fast.

What is a no-shop clause in a term sheet?

A no-shop (or exclusivity) clause is one of the few binding provisions in a term sheet. It prevents the company from soliciting, encouraging, or accepting competing investment proposals for a specified period — typically 30 to 60 days. The purpose is to give the lead investor confidence that the company will not use their term sheet as leverage to shop for a better deal while the investor incurs costs on due diligence and legal work. The no-shop period should be reasonable and tied to the expected closing timeline. Push back on periods longer than 45-60 days, and negotiate for a provision that allows the no-shop to expire automatically if the investor has not completed diligence or delivered draft documents within a specified timeframe. This protects you from an investor who signs a term sheet and then delays indefinitely.